Format

Send to

Choose Destination
Br J Dermatol. 1990 Jan;122(1):99-101.

Oral albendazole for the treatment of cutaneous larva migrans.

Author information

1
Department of Dermatology, Bristol Royal Infirmary, Bristol, U.K.

Abstract

Cutaneous larva migrans is becoming more common in the U.K. with the popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virtually free from side-effects and should, we feel, become the treatment of choice for this condition.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center